Overview

Developed nomenclature and branding system for a rare disease clinical trial program evaluating gene therapy, to be used in materials for HCPs and across patient recruitment and educational/support items.

Plan of Action

• Assess X-Linked Retinitis Pigmentosa (XLRP) trial environment
• Develop relationships with key patient advocacy groups
• Create nomenclature for clinical trial program
• Develop branding system and style for both HCPs and patients
• Refine system based on advocacy feedback
• Launch program (SCENIC) and identify, design, and produce materials for recruitment and education (SKYLINE trial)

Results

• Trial program naming and branding system established
• Program collateral executed for first trial (SKYLINE)
• Materials launched to positive feedback from patients, clinical trialists, and internal corporate audiences
• Set standard for subsequent trial (VISTA)

Trial Program Name Overview

Logos and Brand Style Development

Patient and HCP Collateral